Home
>
National Drug Code (NDC)
>
Dacarbazine
Dacarbazine - 0703-5075-03 - (Dacarbazine)
Drug Information of Dacarbazine
| Product NDC: | 0703-5075 |
| Proprietary Name: | Dacarbazine |
| Non Proprietary Name: | Dacarbazine |
| Active Ingredient(s): | 200 mg/20mL & nbsp; Dacarbazine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dacarbazine
| Product NDC: | 0703-5075 |
| Labeler Name: | Teva Parenteral Medicines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075259 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19980827 |
Package Information of Dacarbazine
| Package NDC: | 0703-5075-03 |
| Package Description: | 10 VIAL in 1 TRAY (0703-5075-03) > 20 mL in 1 VIAL |
NDC Information of Dacarbazine
| NDC Code | 0703-5075-03 |
| Proprietary Name | Dacarbazine |
| Package Description | 10 VIAL in 1 TRAY (0703-5075-03) > 20 mL in 1 VIAL |
| Product NDC | 0703-5075 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dacarbazine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19980827 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc |
| Substance Name | DACARBAZINE |
| Strength Number | 200 |
| Strength Unit | mg/20mL |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
